ADR Biomedical Holdings Inc. (TYO:3750)
Japan flag Japan · Delayed Price · Currency is JPY
771.00
-6.00 (-0.77%)
Nov 18, 2026, 9:57 AM JST

ADR Biomedical Holdings Revenue

ADR Biomedical Holdings had revenue of 9.00M JPY in the quarter ending September 30, 2026, a decrease of -25.00%. This brings the company's total for the last twelve months to 98.00M, up 100.00% year-over-year. In the fiscal year ending March 31, 2026, ADR Biomedical Holdings had annual revenue of 50.00M, down -59.02%. That makes ADR Biomedical Holdings the 44,322nd largest company in the world by revenue and 3,865th in Japan.

Revenue (ttm)
98.00M
Revenue Growth
+100.00%
P/S Ratio
70.79
Revenue / Employee
7.54M
Employees
13
Market Cap
6.88B

Revenue Chart

Revenue by Segment

  • Medical Business 95.64M 78.3%
  • Real Asset Business 26.57M 21.7%
Fiscal year ended Mar 31, 2025 See the full ADR Biomedical Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202650.00M-72.00M-59.02%
Mar 31, 2025122.00M-1.44B-92.18%
Mar 31, 20241.56B-584.00M-27.24%
Mar 31, 20232.14B809.00M60.60%
Mar 31, 20221.34B-53.00M-3.82%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.